Comparison of DPPIV Levels in Serum and Tumour of OSCC Patients and Its Correlation with Active Matrix Metalloproteinases 2 and 9

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2023 Apr 28

PMID 37116157

Authors

Abdolkarim Talebi Taheri

Taghi Lashkarbolouki

Abbas Karimi

Majid Sirati-Sabet

Saeed Karima

Afsaneh Goudarzi

Affiliations

Soon will be listed here.

Abstract

Introduction: The important role of Dipeptidyl Peptidase IV (DPPIV) has been reported in tumour progression of several human cancers. This study demonstrates the DPPIV mRNA expression level and activity in tumour and paired non-tumour tissues of oral squamous cell carcinoma (OSCC) patients and the potential modulation of DPPIV in the metastasis of tumour through regulating MMP2 and MMP9 activities.

Materials And Methods: This study was conducted on 16 OSCC patients. The mRNA expression level of DPPIV was evaluated by RT-qPCR in tumour of OSCC patientsand compared with their paired non-tumour tissues. Additionally, DPPIV activity was measured in serum, tumour and paired non-tumour tissues of OSCC patients. Zymography was performed to measure and compare the activities of MMP2 and MMP9 between tumour and paired non-tumour tissues of OSCC patients.

Results: The results showed significantly higher DPPIV mRNA level and activity in tumour of OSCC patients compared to their paired non-tumour tissues. Tumour DPPIV mRNA expression and activity were positively correlated with activities of MMP2 and MMP9, respectively. Serum DPPIV activity of OSCC patients was lower compared to healthy control and did not show correlation with tumour DPPIV mRNA level.

Conclusion: These data indicate that secreted DPPIV may not originate from the tumour tissue of OSCC patients. Furthermore, increased DPPIV gene expression and activity in tumour of OSCC patients might be involved in the ECM degradation and invasion of OSCC through regulation of MMP2 and MMP9 activities.

Citing Articles

Network pharmacology and molecular docking to explore the potential molecular mechanism of chlorogenic acid treatment of oral squamous cell carcinoma.

Feng Z, Hao P, Yang Y, Xve X, Zhang J Medicine (Baltimore). 2024; 103(45):e40218.

PMID: 39533555 PMC: 11557041. DOI: 10.1097/MD.0000000000040218.

Association of serum and salivary dipeptidyl peptidase-4 (DPP-4) with oral cancerous and precancerous lesions; an observational diagnostic accuracy study.

Abdel Fattah Tarrad N, Shaker O, Abdelkawy M, Hassan S BMC Oral Health. 2024; 24(1):1206.

PMID: 39390508 PMC: 11468375. DOI: 10.1186/s12903-024-04939-7.

References

Lin N, Hsien S, Hsu J, Chen M . Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Sci Rep. 2021; 11(1):15446. PMC: 8322316. DOI: 10.1038/s41598-021-95007-5. View

Yamada S, Yanamoto S, Naruse T, Matsushita Y, Takahashi H, Umeda M . Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma. Pathol Oncol Res. 2016; 22(3):625-32. DOI: 10.1007/s12253-016-0049-6. View

Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View

Morrison M, Vijayasaradhi S, Engelstein D, Albino A, Houghton A . A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med. 1993; 177(4):1135-43. PMC: 2190962. DOI: 10.1084/jem.177.4.1135. View

Sanz B, Larrinaga G, Fernandez-Atucha A, Gil J, Fraile-Bermudez A, Kortajarena M . Obesity parameters, physical activity, and physical fitness are correlated with serum dipeptidyl peptidase IV activity in a healthy population. Heliyon. 2018; 4(5):e00627. PMC: 5986540. DOI: 10.1016/j.heliyon.2018.e00627. View

Pan K, Ohnuma K, Morimoto C, Dang N . CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions. Cureus. 2021; 13(2):e13495. PMC: 7990348. DOI: 10.7759/cureus.13495. View

Pro B, Dang N . CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol. 2004; 19(4):1345-51. DOI: 10.14670/HH-19.1345. View

Li S, Gao L, Liu J, Guo C, Zheng J, Zhi K . The microRNA-10b-Bim axis promotes cancer progression through activating autophagy in oral squamous cell carcinoma. Cell Death Discov. 2022; 8(1):373. PMC: 9411559. DOI: 10.1038/s41420-022-01168-1. View

Bjorklund M, Koivunen E . Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005; 1755(1):37-69. DOI: 10.1016/j.bbcan.2005.03.001. View

10.

Chen W, Kelly T . Seprase complexes in cellular invasiveness. Cancer Metastasis Rev. 2003; 22(2-3):259-69. DOI: 10.1023/a:1023055600919. View

11.

Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T . Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res. 2007; 13(14):4191-200. DOI: 10.1158/1078-0432.CCR-07-0110. View

12.

Boonacker E, van Noorden C . The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol. 2003; 82(2):53-73. DOI: 10.1078/0171-9335-00302. View

13.

Lu Z, Qi L, Bo X, Liu G, Wang J, Li G . Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters. J Res Med Sci. 2014; 18(8):647-52. PMC: 3872602. View

14.

Toth M, Sohail A, Fridman R . Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Biol. 2012; 878:121-35. DOI: 10.1007/978-1-61779-854-2_8. View

15.

Lee B, Kim M, Jang H, Lee H, Ahn K, Lee J . A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line. In Vivo. 2008; 22(5):593-7. View

16.

Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S . Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 2003; 63(9):2278-83. View

17.

Ding L, Fu Y, Zhu N, Zhao M, Ding Z, Zhang X . OXTR stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. Nat Commun. 2022; 13(1):5124. PMC: 9433374. DOI: 10.1038/s41467-022-32787-y. View

18.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

19.

Kikkawa F, Kajiyama H, Shibata K, Ino K, Nomura S, Mizutani S . Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta. 2005; 1751(1):45-51. DOI: 10.1016/j.bbapap.2004.09.028. View

20.

Augoff K, Hryniewicz-Jankowska A, Tabola R, Czapla L, Szelachowski P, Wierzbicki J . Upregulated expression and activation of membrane‑associated proteases in esophageal squamous cell carcinoma. Oncol Rep. 2014; 31(6):2820-6. DOI: 10.3892/or.2014.3162. View